Author | Mark A. Rubin, MD | OncLive

Author | Mark A. Rubin, MD

Articles

Dr. Rubin on Advantages With Whole-Exome Sequencing

April 28, 2016

Video

Mark A. Rubin, MD, professor of Pathology and Laboratory Medicine, vice chairman for Experimental Pathology, director, Translational Research Laboratory Services, Weill Cornell Medicine and New-York Presbyterian, discusses the advantages of whole-exome sequencing and how it compares with targeted sequencing.

x